Full-life cycle management service for drugs
Full-life cycle management service for drugs
We focus on building a full-life cycle management service system for drugs with MAH (Marketing Authorization Holder) as the core and provide complete professional and public services for MAH product realization and clinical use through the way of “investment + platform” to ensure maximum value of MAH products. We have established Liangjiang Medicine, Liujiang Pharma, Lanjiang Pharmaceutical to carry out pharmacological research and Gerui Clinical Research Center to carry out clinical research in order to build CRO+GCP integrated service capability; we have built Dinglian API Production Base and Jinfeng Preparations Production Base to build CMO service capability; meanwhile, we have formed a sound product trading service system around domestic and overseas markets.
Zein Biotechnology have built a CMO industrial service platform with our Changshou API Production Base and Jinfeng Preparations Production Base as the core, both of which were built in accordance with the new Chinese GMP, international cGMP and the latest safety and environmental standards.The capacity of API exceeds one hundred tons, and the preparations production lines cover normal-release and sustained-release capsules, granules, tablets and other dosage forms.